Bexxar as a First Treatment for Follicular Lymphoma

News today from the New England Journal of Medicine. Trials to use Bexxar as a first line treatment for follicular lymphoma! In 75 percent of patients treated with Bexxar, all traces of the cancer disappeared. And more than three-quarters of patients with a complete remission were disease-free after five years.

The Bexxar treatment is already approved for people with follicular lymphoma once conventional chemotherapy has failed. Todays results will led to further study to determine if the US FDA will approve Bexxar as a first-line treatment.


LymphomaInfo Social